Edition:
India

Cortexyme Inc (CRTX.OQ)

CRTX.OQ on NASDAQ Stock Exchange Global Select Market

26.00USD
17 May 2019
Change (% chg)

-- (--)
Prev Close
$26.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$34.73
52-wk Low
$19.75

About

Cortexyme, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on providing disease-modifying therapeutics to treat Alzheimer’s and other degenerative diseases. The Company is focused on a infectious pathogen tied to neurodegeneration in humans and animal models. The Company’s lead drug candidate, COR388,... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $676.35
Shares Outstanding(Mil.): 26.01
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates

No consensus analysis data available.